Samsung Biologics is one of the world's largest contract development and manufacturing organizations (CDMO) for biopharmaceuticals. Headquartered in Incheon, South Korea, the company operates the world's largest biomanufacturing capacity and serves global pharmaceutical clients including major Western pharma companies. Samsung Biologics is expanding into biosimilar development and cell & gene therapy manufacturing, positioning itself at the forefront of APAC's biotech manufacturing ecosystem.
三星生物制剂是全球最大的生物制剂合同开发和制造组织(CDMO),在全球制药供应链中发挥关键作用。
Southeast Asia's leading omnichannel healthcare platform
Japan's largest digital platform for healthcare professionals
China's leading online healthcare services platform powered by AI diagnostics
Leading global CRDMO for biologics drug development and manufacturing
信号将随官方公告被索引后出现在此处。
我们正在追踪该公司的官方渠道,信号将在发现后自动入库。